In a word, our results showed high MACC1 expression is an unfavorable prognostic factor of patients with gynecologic cancers or breast cancer, and the MACC1 may be a potential therapeutic target of gynecologic cancers and breast cancer. This evidence concerns the gene MACC1 and female reproductive organ cancer.